PARTNERS
EVI recognises the power of collaboration and engages with partners worldwide to harness the best knowledge and expertise from leaders in the field of vaccine research and development (R&D).
OUR PARTNERS
Global network for worldwide impact
Abbott
The Netherlands
Projects:
FLUCOP
Areas:
Cross-cutting
Artemis Bio-Support B.V.
The Netherlands
Projects:
FLUCOP
Areas:
Cross-cutting
AstraZeneca AB
Sweden
Projects:
FLUCOP
Areas:
Cross-cutting
Austrian Agency for Health and Food Safety Ltd. (AGES)
Austria
Projects:
VAC2VAC
Areas:
Cross-cutting
BIOASTER - Fondation de Cooperation Scientifique
France
Projects:
TRANSVAC2, TRANSVAC-DS
Areas:
Cross-cutting
Batavia Biosciences B.V.
The Netherlands
Projects:
CEPI-Nipah
Areas:
Nipah virus disease
Bavaria Nordic
Denmark
Projects:
VAC2VAC
Areas:
Cross-cutting
Beijing Science and Technology Linkedin CO LTD, S&T
China
Projects:
SENET
Areas:
Cross-cutting
Beijing University of Chinese Medicine (BUCM)
China
Projects:
SENET
Areas:
Cross-cutting
Biomedical Primate Research Centre (BPRC)
The Netherlands
Projects:
TRANSVAC2, TRANSVAC-DS, VAC2VAC, FLUCOP
Areas:
Cross-cutting
Contact us
We'd love to hear from you!
For the latest updates follow EVI on:
